Research Grade Aducanumab
Aducanumab (brandname:Aduhelm) isanamyloidbeta-directedmonoclonalantibodythattargetsamyloidbetainthebrainsofpeoplewithAlzheimer’storeduceitsbuildup.Aducanumabisamonoclonalantibody (aproteinthathelpsyourimmunesystemtargetotherproteins), anditisdesignedtohelpyourbodyremovesomethingcalledamyloidbetafromthebrain.AmyloidbetaisanimportantproteininvolvedintheprogressionofAlzheimer’sdisease.Aducanumabisgivenintravenously (infusedthroughavein) monthly.AducanumabdoesnotcureAlzheimer’sdisease, butone (oftwo) largeclinicalstudiessuggeststhataducanumabmayslowtheprogressionoftheearliestsymptomsofAlzheimer’sdisease.
Product Specifications
Product Name Alternative
BART, BIIB-037, CAS:1384260-65-4
Expression System
Mammalian Cells
Host
Human
Target
Clonality
Monoclonal
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Purification
Protein A/G purified from cell culture supernatant.
Concentration
2.3mg/ml
Endotoxin
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Form
Liquid
Buffer
0.01M PBS, pH7.4.
Storage Conditions
Notes
For research use only. Not suitable for clinical or therapeutic use.
Buffer pH
0.01M PBS, pH7.4.
Species
Human
Isotype
IgG1-kappa
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items